$AKRO Akero Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Akero Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Akero Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Akero Therapeutics, Inc. for free.
CIK Number: 0001744659
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: AKRO
Company Address: 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO 94080
Phone number: 202-525-8399
Former name: Pippin Therapeutics, Inc.
Akero Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2021 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Sell | S | 30.56 | 3,055 | 93,361 | 167,065 | 170.1 K to 167.1 K (-1.80 %) |
May 04 2021 | AKRO | Akero Therapeutics ... | White William Richard | Chief Financial Off ... | Option Exercise | M | 7.01 | 4,200 | 29,438 | 359,829 | |
May 04 2021 | AKRO | Akero Therapeutics ... | White William Richard | Chief Financial Off ... | Sell | S | 30.56 | 4,200 | 128,352 | 2,270 | 6.5 K to 2.3 K (-64.91 %) |
May 04 2021 | AKRO | Akero Therapeutics ... | White William Richard | Chief Financial Off ... | Buy | M | 7.01 | 4,200 | 29,438 | 6,470 | 2.3 K to 6.5 K (+185.02 %) |
Apr 26 2021 | AKRO | Akero Therapeutics ... | Xu Yuan | Director | Option Exercise | A | 28.79 | 26,000 | 748,540 | 26,000 | |
Feb 02 2021 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Sell | S | 29.92 | 200 | 5,984 | 176,230 | 176.4 K to 176.2 K (-0.11 %) |
Feb 02 2021 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Sell | S | 29.19 | 2,855 | 83,337 | 176,430 | 179.3 K to 176.4 K (-1.59 %) |
Jan 11 2021 | AKRO | Akero Therapeutics ... | Cheng Andrew | President & CEO | Option Exercise | M | 0.62 | 20,000 | 12,300 | 258,712 | |
Jan 11 2021 | AKRO | Akero Therapeutics ... | Cheng Andrew | President & CEO | Gift | G | 0.00 | 3,000 | 0 | 359,989 | 363 K to 360 K (-0.83 %) |
Jan 11 2021 | AKRO | Akero Therapeutics ... | Cheng Andrew | President & CEO | Buy | M | 0.62 | 20,000 | 12,300 | 362,989 | 343 K to 363 K (+5.83 %) |
Jan 11 2021 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Option Exercise | M | 0.62 | 7,500 | 4,613 | 35,296 | |
Jan 11 2021 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Sell | S | 28.12 | 10,000 | 281,200 | 179,285 | 189.3 K to 179.3 K (-5.28 %) |
Jan 11 2021 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Buy | M | 0.62 | 7,500 | 4,613 | 189,285 | 181.8 K to 189.3 K (+4.13 %) |
Dec 29 2020 | AKRO | Akero Therapeutics ... | Cheng Andrew | President & CEO | Option Exercise | M | 0.62 | 7,480 | 4,638 | 278,712 | |
Dec 29 2020 | AKRO | Akero Therapeutics ... | Cheng Andrew | President & CEO | Option Exercise | M | 0.62 | 7,480 | 4,638 | 278,712 |